HeadlinesNews Stand NG

Indonesian pharmaceutical firm plans Lagos factory for local production

Indonesian pharmaceutical firm plans Lagos factory for local production
Photo courtesy of Punch Newspaper · Verified via News Stand NG
Source Attribution: Punch Newspaper

News Stand NG operates under ethical news aggregation guidelines. Source: Punch Newspaper. To read the unabridged investigative reporting and full gallery, visit the original publication.

Read Full Story on Punch Newspaper
AI Executive Briefing
Verified Synthesis~34s read
Suwarno said the planned facility formed part of the group’s strategy to strengthen its presence in Nigeria, which it considers a strategic market for its pharmaceutical products and wider African operations. Photo: Deborah Musa Indonesian pharmaceutical company, Dexa Group, has announced plans to expand its operations in Nigeria, with local production of its Boska pain-relief tablets expected to begin in 2028.
Context & Background
  • ✦The director said the group was establishing a production factory in Ilupeju, Lagos, which was already 80 per cent complete.
Key Figures & Named Entities
2028:Photo: Deborah Musa Indonesian pharmaceutical company, Dexa Group, has announced plans to expand its operations in Nigeria, with local production of its Boska pain-relief tablets expected to begin in 2028.Saturday:The Director of PT Fonko International Pharmaceuticals, Benny Suwarno, disclosed this on Saturday, during a courtesy visit by officials of the Indonesian Embassy in Nigeria, where he presented an overview of Dexa Group’s operations, research investments and expansion plans.2028:He said the building was ready for the next phase of development, which would involve installing the necessary machinery, testing production processes and completing regulatory requirements ahead of the planned commencement of operations in 2028.
Outlook & Next Steps
Follow original publisher reporting for subsequent developments, official responses, and verified updates.
Key Takeaways
Verified Extract
  • ✦Suwarno said the planned facility formed part of the group’s strategy to strengthen its presence in Nigeria, which it considers a strategic market for its pharmaceutical products and wider African operations.
  • ✦Photo: Deborah Musa Indonesian pharmaceutical company, Dexa Group, has announced plans to expand its operations in Nigeria, with local production of its Boska pain-relief tablets expected to begin in 2028.
  • ✦The director said the group was establishing a production factory in Ilupeju, Lagos, which was already 80 per cent complete.
Key Facts:2028: Photo: Deborah Musa Indonesian pharmaceutical company, Dexa Group, has announced plans to expand its operations in Nigeria, with local production of its Boska pain-relief tablets expected to begin in 2028.Saturday: The Director of PT Fonko International Pharmaceuticals, Benny Suwarno, disclosed this on Saturday, during a courtesy visit by officials of the Indonesian Embassy in Nigeria, where he presented an overview of Dexa Group’s operations, research investments and expansion plans.2028: He said the building was ready for the next phase of development, which would involve installing the necessary machinery, testing production processes and completing regulatory requirements ahead of the planned commencement of operations in 2028.
Editorial Excerpt

Indonesian pharmaceutical company, Dexa Group, has announced plans to expand its operations in Nigeria, with local production of its Boska pain-relief

Frequently Asked Questions About This Story

What is the latest development regarding Lagos State?

Suwarno said the planned facility formed part of the group’s strategy to strengthen its presence in Nigeria, which it considers a strategic market for its pharmaceutical products and wider African operations.

Who are the key organizations or public figures mentioned?

The primary parties identified in this coverage include Lagos State.

What timeline or key figures were confirmed?

Photo: Deborah Musa Indonesian pharmaceutical company, Dexa Group, has announced plans to expand its operations in Nigeria, with local production of its Boska pain-relief tablets expected to begin in 2028.

Related Topics & Entities

More Coverage on This Story